Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, P.O. Box KB 4236, Accra, Ghana.
BMC Med Genomics. 2024 Nov 12;17(1):267. doi: 10.1186/s12920-024-02043-x.
In Africa, the problem of carbapenem-resistant Enterobacteriaceae (CRE) is aggravated by many factors. This systematic review attempted to describe the current status of the molecular epidemiology of carbapenem resistance in West Africa (WA).
Articles published from 16 West African countries on the molecular epidemiology of carbapenem resistance were reviewed. An extensive literature search was carried out in PubMed, Scopus, Web of Science, and African Journals Online (AJOL) using specific keywords. The meta-analysis and forest plots of major pathogens and carbapenem resistance genes were done using the Open Meta-Analyst, Task Order # 2 software. The data were analysed in binary random model effects by the DerSimonian-Laird method at a 95% confidence interval.
Of the 431 articles found in our initial search, 60 (13.92%) were considered suitable for inclusion. Only seven of the 16 West African countries formed part of the analysis, Nigeria (23/60), Ghana (19/60), Burkina Faso (7/60), Senegal (6/60), Benin (2/60), Mali (2/60), and Togo (1/60). Also, 80% (48/60) of the studies used clinical samples, 16.67% (10/60) used environmental samples, and 3.33% (2/60) used animal samples. The average prevalence was highest in Acinetobacter baumannii (18.6%; 95% CI = 14.0-24.6, I = 97.9%, p < 0.001), followed by Pseudomonas aeruginosa (6.5%; 95% CI = 3.1-13.4, I = 96.52%, p < 0.001), Klebsiella pneumoniae (5.8%; 95% CI = 4.2-7.9, I = 98.06%, p < 0.001) and Escherichia coli (4.1%; 95% CI = 2.2-7.7, I = 96.68%, p < 0.001). The average prevalence of the blaNDM gene was 10.6% (95% CI = 7.9-14.3, I = 98.2%, p < 0.001), followed by 3.9% (95% CI: 1.8-8.3, I = 96.73%, p < 0.001) for blaVIM and 3.1% (95% CI: 1.7-5.8, I = 91.69%, p < 0.001) for blaOXA-48.
In West Africa, K. pneumoniae, E. coli, A. baumannii, and P. aeruginosa are the main CRE with blaNDM, blaVIM, and blaOXA-48 being the predominant carbapenem resistance genes. In view of these results, ongoing CRE surveillance combined with antimicrobial stewardship improved, laboratory detection methods, and adherence to infection control practices will be needed to control the spread of CRE.
在非洲,碳青霉烯类耐药肠杆菌科(CRE)的问题因多种因素而加剧。本系统评价试图描述西非(WA)碳青霉烯类耐药的分子流行病学现状。
综述了在 16 个西非国家发表的关于碳青霉烯类耐药的分子流行病学的文章。在 PubMed、Scopus、Web of Science 和 African Journals Online(AJOL)上使用特定关键字进行了广泛的文献检索。使用 Open Meta-Analyst、Task Order # 2 软件对主要病原体和碳青霉烯类耐药基因的荟萃分析和森林图进行了分析。使用 DerSimonian-Laird 方法在 95%置信区间内对二进制随机模型效应进行了数据分析。
在我们最初的搜索中发现了 431 篇文章,其中 60 篇(13.92%)被认为适合纳入分析。只有 7 个西非国家(尼日利亚[23/60]、加纳[19/60]、布基纳法索[7/60]、塞内加尔[6/60]、贝宁[2/60]、马里[2/60]和多哥[1/60])参与了分析。此外,80%(48/60)的研究使用了临床样本,16.67%(10/60)使用了环境样本,3.33%(2/60)使用了动物样本。平均流行率最高的是鲍曼不动杆菌(18.6%;95%CI=14.0-24.6,I=97.9%,p<0.001),其次是铜绿假单胞菌(6.5%;95%CI=3.1-13.4,I=96.52%,p<0.001),肺炎克雷伯菌(5.8%;95%CI=4.2-7.9,I=98.06%,p<0.001)和大肠埃希菌(4.1%;95%CI=2.2-7.7,I=96.68%,p<0.001)。blaNDM 基因的平均流行率为 10.6%(95%CI=7.9-14.3,I=98.2%,p<0.001),其次是 blaVIM(3.9%;95%CI:1.8-8.3,I=96.73%,p<0.001)和 blaOXA-48(3.1%;95%CI:1.7-5.8,I=91.69%,p<0.001)。
在西非,肺炎克雷伯菌、大肠杆菌、鲍曼不动杆菌和铜绿假单胞菌是主要的 CRE,blaNDM、blaVIM 和 blaOXA-48 是主要的碳青霉烯类耐药基因。鉴于这些结果,需要持续进行 CRE 监测,结合抗菌药物管理、改善实验室检测方法和遵守感染控制措施,以控制 CRE 的传播。